AQSTAquestive Therapeutics, Inc.
$4.00-42% 1Y
$4.00
$2.9552 weeks$7.01
Is the price fair?
What AQST's price assumes
Aquestive Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 9.64× revenue.
9.64
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 8.83
EV / sales
Details›
- EV / EBIToperating margin −98%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 8.83
- Market capitalisation125.5 million shares, counted Aug 7, 2026
- $501M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Drug Manufacturers, Specialty & Generic
Ranks #35 of 39 by RyuScore